What are the percentage risks of maternal and neonatal complications for a healthy woman undergoing a planned cesarean delivery?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 12, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Cesarean Section Risks: Patient Counseling Guide

For a healthy woman undergoing a planned cesarean delivery at term, you should counsel that approximately 2-3% will experience serious maternal complications, with infection being the most common risk affecting about 15% of patients, while neonatal risks remain very low at less than 1% for serious complications.

Maternal Risks - Short-Term Complications

Infection Risks (Most Common)

  • Overall infection rate: 15% compared to 10% with planned vaginal delivery 1
  • Specific infection types with cesarean:
    • Wound infection: 2.7 times higher risk 1
    • Mastitis: 2.0 times higher risk 1
    • Urinary tract infection: 1.5 times higher risk 1
    • Endometritis: 1.2 times higher risk 1
  • To prevent one infection, approximately 20 women would need to avoid cesarean (number needed to harm = 17) 1

Serious Maternal Complications

  • Overall severe morbidity: 2.7% (27.3 per 1,000 deliveries) versus 0.9% with planned vaginal delivery 2
  • Specific serious risks include:
    • Cardiac arrest: 5 times higher risk (approximately 0.16% or 1.6 per 1,000) 2
    • Wound hematoma: 5 times higher risk 2
    • Blood clots (venous thromboembolism): 2.2 times higher risk (approximately 0.08% versus 0.05%) 2, 1
    • Hysterectomy: 3.2 times higher risk 2
    • Major infection requiring IV antibiotics: 3 times higher risk 2
    • Anesthetic complications: 2.3 times higher risk 2

Maternal Mortality

  • Maternal death risk: 13.4 per 100,000 cesarean deliveries versus 3.8 per 100,000 for planned vaginal delivery 3
  • This translates to approximately 0.013% absolute risk, though this difference was not statistically significant in some studies 2

Hospital Stay

  • Average 1.5 days longer hospitalization compared to vaginal delivery 2

Neonatal Risks

Immediate Neonatal Complications

  • Severe neonatal morbidity or death: 4.3% with planned cesarean at 39 weeks versus 5.4% with expectant management 4
  • This composite includes respiratory support needs, low Apgar scores, seizures, infections, and birth trauma 4

Perinatal Mortality

  • Perinatal death: 0.5 per 1,000 (0.05%) with planned cesarean versus 1.3 per 1,000 with trial of labor 3

Risks with Future Pregnancies (Critical for Counseling)

Placental Complications in Subsequent Pregnancies

  • Placenta previa risk increases with each cesarean: 5
    • After 1st cesarean: 0.9% (9 per 1,000)
    • After 2nd cesarean: 1.7% (17 per 1,000)
    • After 3rd cesarean: 3.0% (30 per 1,000)
  • Placenta accreta risk escalates dramatically: 5
    • After 1st cesarean: 0.25-3%
    • After 4th cesarean: 2.17% (217 per 10,000)

Other Repeat Cesarean Risks

  • After 2nd cesarean, risks include: 5
    • Wound/uterine hematoma: 4-6%
    • Blood transfusion: 1-4%
    • Hysterectomy: 0.5-4%

Common Pitfalls in Counseling

Avoid Underestimating Cumulative Risk

The most critical counseling point is that each additional cesarean exponentially increases risks of abnormal placentation, hysterectomy, and surgical complications 5, 6. Women planning multiple children need to understand this compounding risk.

Timing Matters for Planned Cesarean

Schedule at 39-40 weeks gestation to minimize neonatal respiratory complications while avoiding spontaneous labor 5. Earlier delivery increases neonatal morbidity.

Present Absolute Numbers, Not Just Relative Risk

While relative risks sound dramatic (e.g., "5 times higher"), the absolute risks remain low for most serious complications. For example, cardiac arrest increases from 0.03% to 0.16% - still very rare 2.

Patient-Friendly Summary Framework

Use this structure for counseling:

  1. Common problems (10-15% chance): Infection, longer recovery, more pain
  2. Uncommon but serious (2-3% chance): Severe bleeding, blood clots, need for hysterectomy
  3. Rare but life-threatening (<0.1% chance): Cardiac arrest, maternal death
  4. Future pregnancy impact: Each cesarean increases placenta problems in next pregnancy
  5. Baby risks: Very low for planned cesarean at 39 weeks (less than 1% serious problems)

The decision between cesarean and vaginal delivery should weigh these risks against individual medical indications, with recognition that for low-risk nulliparous women, elective induction at 39 weeks actually reduces cesarean risk to 18.6% versus 22.2% with expectant management 4.

Related Questions

What is the most appropriate next step in management for a 39-year-old woman, gravida 3, para 2, at 39 weeks' gestation, with spontaneous rupture of membranes, contractions, 70% cervical effacement, 7 cm dilation, and no change in station after 4 hours, with normal fetal heart rate and contractions of 275 Montevideo units?
What are the steps to perform a cesarean section (C-section)?
What are the indications for a Cesarean (C-Section) delivery?
What are the recommended postpartum management steps for a woman after cesarean delivery, including pain control, wound care, venous thromboembolism prophylaxis, anemia treatment, breastfeeding support, activity restrictions, urinary monitoring, contraception, and follow‑up?
How can a 6-week pregnant woman with a past history of cesarean section (C-section) reduce medical intervention in her current pregnancy?
What is the appropriate dosing regimen of Alenia (nitazoxanide) for treating Giardia lamblia and Cryptosporidium parvum diarrhea in otherwise healthy adults and adolescents (≥12 years) and children (1–11 years), and what are its contraindications, precautions (including pregnancy and lactation), and common adverse effects?
What is the recommended evaluation and management of a retroverted uterus in asymptomatic and symptomatic women, including treatment options and considerations during pregnancy?
What physiotherapy management should be provided for a patient with diabetes insipidus to ensure safe exercise, maintain fluid balance, and prevent dehydration?
Can the elevated BUN (29 mg/dL) and serum creatinine (1.48 mg/dL) with hyperkalemia (potassium 5.7 mEq/L) be due to a hemolyzed blood specimen in a patient who recently discontinued lisinopril (40 mg)?
In an elderly skilled‑nursing‑facility resident with a left‑basilar infiltrate, how can I distinguish a persistent infiltrate from a recurrent infiltrate?
In a patient on lisinopril who is dehydrated and now has elevated blood urea nitrogen, serum creatinine, and serum potassium, is this acute kidney injury from the ACE inhibitor and volume depletion, and what immediate management steps should be taken?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.